Public Release:  Study shows answers for treating obesity-related diseases may reside in fat tissue

Boston University Medical Center

(Boston) - Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have shown that the quality - not just the quantity - of adipose, or fat, tissue is a significant contributing factor in the development of inflammation and vascular disease in obese individuals. The study, which is a special feature on the iPAD version of the Journal of the American College of Cardiology, provides compelling evidence that the answer to treating cardiovascular disease and other obesity-related disorders, such as type 2 diabetes and cancer, might be found in the adipose tissue itself.

While obesity is a leading preventable cause of death in the United States, its prevalence continues to increase rapidly among individuals of all ethnicities and age groups. According to the National Institutes of Health, more than 33 percent of men and women above the age of 20 in the United States are obese and 68% are overweight.

Led by Noyan Gokce, MD, a cardiologist at BMC and an associate professor of medicine at BUSM, the researchers examined adipose tissue samples from both lean and obese individuals. The study subjects, all of whom were receiving care at BMC, included 109 obese men and women and 17 lean men and women between the ages of 21 and 55.

After obtaining the samples, the tissue was biopsied and evaluated for the amount of inflammation present in the tissue. They then performed a vascular ultrasound on the forearm artery to examine blood vessel function. After compiling the information, the researchers saw that lean individuals exhibited no adipose inflammation and normal vascular function whereas the obese individuals exhibited significant inflammation and poor vascular function.

While these study findings are consistent with other epidemiological obesity studies, this research team identified that 30 percent of the obese subjects demonstrated reduced fat inflammation, less insulin resistance, and their vascular function was similar to a lean person despite severe obesity. The study suggests that humans prone to inflammation in association with weight gain may be more susceptible to cardiovascular and metabolic disease risks.

"While it is widely believed that obesity and inflammation are linked to cardiovascular disease, this study shows not all obese individuals exhibit inflammation that can lead to cardiovascular disease, type 2 diabetes and cancer," said Gokce, the study's senior author. "Once we identify what harmful products adipose tissue is producing that is linked to causing systemic inflammation, we can explore treatments against it that could potentially combat the development of several debilitating obesity-related disorders."

###

This study was funded by The National Institutes of Health. Other researchers involved with the study include: Melissa G. Farb, PhD, Sherman Bigornia, MA, Melanie Mott, MS, RD, Kahraman Tanriverdi, PhD, Kristine M. Morin, MPH, Jane E. Freedman, MD, Lija Joseph, MD, Donald T. Hess, MD, Caroline M. Apovian, MD, and Joseph A. Vita, MD.

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 508-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. Committed to providing high-quality health care to all, the hospital offers a full spectrum of pediatric and adult care services including primary and family medicine and advanced specialty care with an emphasis on community-based care. Boston Medical Center offers specialized care for complex health problems and is a leading research institution. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet--15 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit www.bmc.org

About Boston University School of Medicine

Originally established in 1848 as the New England Female Medical College, and incorporated into Boston University in 1873, Boston University School of Medicine today is a leading academic medical center with an enrollment of more than 700 medical students and more than 800 masters and PhD students. Its 1,246 full and part-time faculty members generated more than $335 million in funding in the 2009-2010 academic year for research in amyloidosis, arthritis, cardiovascular disease, cancer, infectious disease, pulmonary disease and dermatology among others. The School is affiliated with Boston Medical Center, its principal teaching hospital, the Boston and Bedford Veterans Administration Medical Centers and 16 other regional hospitals as well as the Boston HealthNet.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.